US 12070502
Process for reducing subvisible particles in a pharmaceutical formulation
granted A61KA61K39/39591A61K47/22
Quick answer
US patent 12070502 (Process for reducing subvisible particles in a pharmaceutical formulation) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 48
- CPC classes
- A61K, A61K39/39591, A61K47/22, A61K47/26